AU Patent

AU2018238138A1 — Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

Assigned to Arbutus Biopharma Corp · Expires 2019-10-17 · 7y expired

What this patent protects

The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention are capsid inhi…

USPTO Abstract

The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention are capsid inhibitors. (Formula I)

Drugs covered by this patent

Patent Metadata

Patent number
AU2018238138A1
Jurisdiction
AU
Classification
—
Expires
2019-10-17
Drug substance claim
No
Drug product claim
No
Assignee
Arbutus Biopharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.